“New therapeutic strategies in neurodegenerative diseases”, interview with one of the main researchers of our project, Antonio Cuadrado. An initiative from the UAM Foundation to publicize the research carried out at this institution and its potential to be applied for the benefit of society. You can see the interview here.
We continue increasing the number of doctors in the NRF24AD project. This time it was Sheila Abril’s turn, who presented her doctoral thesis entitled Novel multitarget chiral α7-nAChRs ligands with neuroprotective properties for Alzheimer’s Disease treatment on October 31 at the UAM School of Medicine. Sheila’s work has been supervised by doctors Rafael León Martínez … Read more Doctoral Thesis – Sheila Abril
On October 11, Natalia Robledinos (GT2 group) and Clara Herrera (GT3 group) defended their doctoral thesis entitled “Orchestration of the neural stem cell fate by NRF2 and TAZ” and “Melatonin- and resveratrol-based multitarget-directed agents for Alzheimer’s disease and photoswitchable muscular nicotinic receptor ligands” respectively. Thank you very much for your effort and the contributions you … Read more PhD Thesis Natalia Robledinos and Clara Herrera
On July 8, Clara Herrera received the Lilly Award for early-stage researchers from the Spanish Society of Therapeutic Chemistry (SEQT) as recognition to her work entitled New neurogenic inducers with combined activities in key targets related to Alzheimer’s disease. The ceremony took place during the XIX edition of the SEQT congress, in Vitoria-Gasteiz, and was … Read more 2019 Lilly Award for Early-Stage Researchers
On June 26, the 28th edition of Farmadrid took place at La Princesa University Hospital. These annual meetings have been held since 1991, with the support of the Teófilo Hernando Foundation, with the aim of sharing the pharmacological research carried out at universities, hospitals, and pharmaceutical laboratories of the Community of Madrid. Several PhD students … Read more Farmadrid 28
A team of researchers from different universities and research centers form the United States, Japan, Australia, Sweden, United Kingdom and Austria led by Dr. Peter T. Nelson has identified a new dementia traditionally diagnosed as Alzheimer’s Disease (AD). This new proteinopathy has been called LATE (limbic-predominant age-related TDP-43 encephalopathy), and about a quarter of people … Read more New type of dementia identified
On April 5, 2019 Patrycja Michalska Dziama, member of the NRF24AD project (GT1), defended her doctoral thesis entitled “Novel Nrf2 inducers with multitarget activities for the treatment of neurodegenerative diseases”, under the supervision of Dr. Rafael Léon and Dr. Manuela G. López. Patrycja’s thesis project proposes the synthesis of compounds directed to multiple targets with … Read more Patrycja Michalska’s doctoral thesis
Dr. Rafaél León made the first presentation of the “Teófilo Hernando” Forum of Young Researchers, organized by the Teófilo Hernando Foundation and the Royal National Academy of Medicine. This initiative intends to create a high institutional prestige forum so that noted Spanish young researchers present their most relevant work (mainly whithin the biomedical field) with … Read more First presentation of the “Teófilo Hernando” Forum of Young Researchers by Dr. Rafael León